•
Sep 30, 2013

Cocrystal Pharma Q3 2013 Earnings Report

Total Revenue
$2.09M
Previous year: $4.89M
-57.4%
EPS
-$0.02
Previous year: $0.12
-116.7%
Gross Profit
$1.11M
Previous year: $2.02M
-45.1%
Cash and Equivalents
$1.84M
Previous year: $82.6K
+2130.7%
Free Cash Flow
-$988K
Total Assets
$7.6M
Previous year: $8.26M
-8.0%

Cocrystal Pharma

Cocrystal Pharma